Abstract

Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10% of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar. Non-Hodgkin lymphoma represents a wide spectrum of illnesses that vary from the most indolent to the most aggressive malignancies. They arise from lymphocytes that are at various stages of development, and the characteristics of the specific lymphoma subtype reflect those of the cell from which they originated. Since this topic was last reviewed in The Lancet in 2012, advances in understanding the biology and genetics of non-Hodgkin lymphoma and the availability of new diagnostic methods and therapies have improved our ability to manage patients with this disorder.

Original languageEnglish (US)
Pages (from-to)298-310
Number of pages13
JournalThe Lancet
Volume390
Issue number10091
DOIs
StatePublished - Jul 15 2017

Fingerprint

Non-Hodgkin's Lymphoma
Lymphoma
Primary Care Physicians
Hodgkin Disease
Lymphocytes
Physicians
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Non-Hodgkin lymphoma. / Armitage, James Olen; Gascoyne, Randy D.; Lunning, Matthew A; Cavalli, Franco.

In: The Lancet, Vol. 390, No. 10091, 15.07.2017, p. 298-310.

Research output: Contribution to journalReview article

Armitage, JO, Gascoyne, RD, Lunning, MA & Cavalli, F 2017, 'Non-Hodgkin lymphoma', The Lancet, vol. 390, no. 10091, pp. 298-310. https://doi.org/10.1016/S0140-6736(16)32407-2
Armitage, James Olen ; Gascoyne, Randy D. ; Lunning, Matthew A ; Cavalli, Franco. / Non-Hodgkin lymphoma. In: The Lancet. 2017 ; Vol. 390, No. 10091. pp. 298-310.
@article{24ec20f40cd94db19a75369add961fe0,
title = "Non-Hodgkin lymphoma",
abstract = "Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10{\%} of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar. Non-Hodgkin lymphoma represents a wide spectrum of illnesses that vary from the most indolent to the most aggressive malignancies. They arise from lymphocytes that are at various stages of development, and the characteristics of the specific lymphoma subtype reflect those of the cell from which they originated. Since this topic was last reviewed in The Lancet in 2012, advances in understanding the biology and genetics of non-Hodgkin lymphoma and the availability of new diagnostic methods and therapies have improved our ability to manage patients with this disorder.",
author = "Armitage, {James Olen} and Gascoyne, {Randy D.} and Lunning, {Matthew A} and Franco Cavalli",
year = "2017",
month = "7",
day = "15",
doi = "10.1016/S0140-6736(16)32407-2",
language = "English (US)",
volume = "390",
pages = "298--310",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10091",

}

TY - JOUR

T1 - Non-Hodgkin lymphoma

AU - Armitage, James Olen

AU - Gascoyne, Randy D.

AU - Lunning, Matthew A

AU - Cavalli, Franco

PY - 2017/7/15

Y1 - 2017/7/15

N2 - Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10% of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar. Non-Hodgkin lymphoma represents a wide spectrum of illnesses that vary from the most indolent to the most aggressive malignancies. They arise from lymphocytes that are at various stages of development, and the characteristics of the specific lymphoma subtype reflect those of the cell from which they originated. Since this topic was last reviewed in The Lancet in 2012, advances in understanding the biology and genetics of non-Hodgkin lymphoma and the availability of new diagnostic methods and therapies have improved our ability to manage patients with this disorder.

AB - Lymphomas can affect any organ in the body, present with a wide range of symptoms, and be seen by primary care physicians and physicians from most specialties. They are traditionally divided into Hodgkin's lymphoma (which accounts for about 10% of all lymphomas) and non-Hodgkin lymphoma, which is the topic of this Seminar. Non-Hodgkin lymphoma represents a wide spectrum of illnesses that vary from the most indolent to the most aggressive malignancies. They arise from lymphocytes that are at various stages of development, and the characteristics of the specific lymphoma subtype reflect those of the cell from which they originated. Since this topic was last reviewed in The Lancet in 2012, advances in understanding the biology and genetics of non-Hodgkin lymphoma and the availability of new diagnostic methods and therapies have improved our ability to manage patients with this disorder.

UR - http://www.scopus.com/inward/record.url?scp=85011094202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011094202&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(16)32407-2

DO - 10.1016/S0140-6736(16)32407-2

M3 - Review article

VL - 390

SP - 298

EP - 310

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10091

ER -